Review



rho activation assay biochemistry kit  (Cytoskeleton Inc)


Bioz Verified Symbol Cytoskeleton Inc is a verified supplier
Bioz Manufacturer Symbol Cytoskeleton Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Cytoskeleton Inc rho activation assay biochemistry kit
    Rho Activation Assay Biochemistry Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 49 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a+rho+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay/pm42219803-34-1-6
    Average 94 stars, based on 49 article reviews
    rho activation assay biochemistry kit - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Activation Assay:

    Article Title: Tumor Treating Fields (TTFields) Therapy in Unresectable Pleural Mesothelioma: Overview of Efficacy, Safety, and Future Outlook.
    Article Snippet: .. The alterations in microtubule organization led to increased activation of guanine nucleotide exchange factor-H1 (GEFH1), triggering the Ras homolog family member A (Rho A)/ Rho-associated coiled-coil kinase (ROCK) signaling cascade (a key regulator of the cytoskeleton), and ultimately resulting in the formation of focal adhesions and actin reorganization [48]. ..

    Article Title: G Protein-Coupled estrogen receptor negatively regulates cell rigidity and osteogenic differentiation in bone marrow-derived mesenchymal stem cells.
    Article Snippet: Estrogen plays pivotal roles in regulating bone formation and mineralization via estrogen receptors.. Although the expression of G protein-coupled estrogen receptor-1 (GPER-1) is widespread in eukaryotic cells like bone marrow-derived mesenchymal stem cells (BMSCs), the precise mechanism by which this membrane receptor dictates BMSC differentiation has not been thoroughly established.. In this study, we investigated whether GPER1 regulates BMSC osteogenesis by modulating cytoskeletal dynamics and cellular rigidity via the Ras homolog family member A (RhoA) signaling pathway.

    Article Title: The Edwardsiella T3SS effector EseQ promotes invasion by altering the cell’s cytoskeleton and disrupting the epithelial barrier
    Article Snippet: Images were captured using a confocal laser scanning microscope (NLO-LSM 710, Carl Zeiss). .. RhoA activation was analyzed using a G-LISA RhoA Activation Assay Biochem Kit (Cytoskeleton, Inc.). .. In brief, the following treatments were performed on HeLa cells: transfection with either pcDNA- eseQ -HA or pcDNA- esaB -HA (the negative control) and treatment with 20 μM nocodazole (Sigma-Aldrich) for 30 min (the positive control).

    Article Title: The Edwardsiella T3SS effector EseQ promotes invasion by altering the cell's cytoskeleton and disrupting the epithelial barrier.
    Article Snippet: Images were captured using a confocal laser scanning microscope (NLO-LSM 710, Carl Zeiss). .. RhoA activation was analyzed using a G-LISA RhoA Activation Assay Biochem Kit (Cytoskeleton, Inc.). .. In brief, the following treatments were performed on HeLa cells: transfection with either pcDNA-eseQ-HA or pcDNA-esaB-HA (the negative control) and treatment with 20 μM nocodazole (Sigma-Aldrich) for 30 min (the positive control).

    Article Title: FGF12 induces aberrant mechanosignaling in aortic smooth muscle cells during thoracic aortic aneurysm formation in Marfan syndrome mice
    Article Snippet: .. Active RhoA (GTP-bound RhoA) was measured using a RhoA activation assay kit (Cytoskeleton). ..

    Article Title: FGF12 induces aberrant mechanosignaling in aortic smooth muscle cells during thoracic aortic aneurysm formation in Marfan syndrome mice.
    Article Snippet: .. Active RhoA pulldown assay Active RhoA (GTP-bound RhoA) was measured using a RhoA activation assay kit (Cytoskeleton). ..

    Pull Down Assay:

    Article Title: G Protein-Coupled estrogen receptor negatively regulates cell rigidity and osteogenic differentiation in bone marrow-derived mesenchymal stem cells.
    Article Snippet: Estrogen plays pivotal roles in regulating bone formation and mineralization via estrogen receptors.. Although the expression of G protein-coupled estrogen receptor-1 (GPER-1) is widespread in eukaryotic cells like bone marrow-derived mesenchymal stem cells (BMSCs), the precise mechanism by which this membrane receptor dictates BMSC differentiation has not been thoroughly established.. In this study, we investigated whether GPER1 regulates BMSC osteogenesis by modulating cytoskeletal dynamics and cellular rigidity via the Ras homolog family member A (RhoA) signaling pathway.

    Western Blot:

    Article Title: The Edwardsiella T3SS effector EseQ promotes invasion by altering the cell’s cytoskeleton and disrupting the epithelial barrier
    Article Snippet: .. The samples were then subjected to immunoblotting using a rabbit anti-RhoA antibody (dilution 1:3,000, Cytoskeleton, Inc.). ..

    Article Title: The Edwardsiella T3SS effector EseQ promotes invasion by altering the cell's cytoskeleton and disrupting the epithelial barrier.
    Article Snippet: .. The samples were then subjected to immunoblotting using a rabbit anti-RhoA antibody (dilution 1:3,000, Cytoskeleton, Inc.). ..



    Similar Products

    rho activation assay biochemistry kit  (Cytoskeleton Inc)
    94
    Cytoskeleton Inc rho activation assay biochemistry kit
    Rho Activation Assay Biochemistry Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a+rho+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay/pm42219803-34-1-6
    Average 94 stars, based on 1 article reviews
    rho activation assay biochemistry kit - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    rho gtpase pull down assay kit  (Cytoskeleton Inc)
    94
    Cytoskeleton Inc rho gtpase pull down assay kit
    Rho Gtpase Pull Down Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a+rho+activation+assay+kit/RhoA+G-LISA+GTPase+Activation+Assay/pm42155732-83-23-28
    Average 94 stars, based on 1 article reviews
    rho gtpase pull down assay kit - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    rho activation assay kit  (Cell Biolabs Inc)
    86
    Cell Biolabs Inc rho activation assay kit
    Rho Activation Assay Kit, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a+rho+activation+assay+kit/activation+assay+cdc42+combo+kit+rac1+rhoa/pm41857010-157-9-13
    Average 86 stars, based on 1 article reviews
    rho activation assay kit - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    rho activation assay biochem kit  (Cytoskeleton Inc)
    96
    Cytoskeleton Inc rho activation assay biochem kit
    Rho Activation Assay Biochem Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a+rho+activation+assay+kit/RhoA+Pull-down+Activation+Assay+Biochem+Kit/bio_rxiv__64898__2026__02__18__706611-263-12-17
    Average 96 stars, based on 1 article reviews
    rho activation assay biochem kit - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    active rho detection kit  (Cell Signaling Technology Inc)
    93
    Cell Signaling Technology Inc active rho detection kit
    <t>RHOA</t> and MYO9B play roles in the ability of the RGDKGE collagen peptide (P2) to modulate CD8 + T-cell migration on denatured collagen-IV (Den-Coll-IV). A and B: Whole cell lysates were prepared from Jurkat T cells treated with the P2 or control peptide (CP; A ) or dimethyl sulfoxide (DMSO) buffer control or RHOA inhibitor rhosin ( B ) and analyzed by Western blot analysis for total and activated RHOA using an active <t>RHO</t> detection kit. C and D: Quantification of Jurkat T-cell migration on denatured collagen-IV ( C ) or native collagen-IV (Nat-Coll-IV; D ) in the presence of DMSO or RHOA inhibitor rhosin. C: Data represent change in cell migration from four independent experiments with control DMSO treatment set to 100% for comparison. D: Data represent change in cell migration from three independent experiments with control DMSO treatment set to 100% for comparison. E and F: Cell lysates were prepared from Jurkat T cells treated with the P2 or CP ( E ) or DMSO or SRC non-receptor tyrosine kinase (SRC) inhibitor ( F ), and analyzed by Western blot analysis for MYO9B. G: Western blot analysis for MYO9B levels in control or MYO9B-specific siRNA-transfected Jurkat T cells. H and I: Quantification of control and MYO9B-specific knockdown Jurkat T-cell migration on denatured collagen-IV ( H ) or native collagen-IV ( I ). H: Data represent change in cell migration from four independent experiments with control siRNA treatment set to 100% for comparison. I: Data represent change in cell migration from two independent experiments with control siRNA treatment set to 100% for comparison. J: Quantification of MYO9B knockdown Jurkat T-cell migration on denatured collagen-IV in the presence of CP or P2. Data represent change in cell migration from three independent experiments with control CP treatment set to 100% for comparison. K: Example of F-actin polarization ( arrows ) in control or MYO9B-specific siRNA-transfected Jurkat T cells seeded onto denatured collagen-IV. L: Quantification of the mean percentage of F-actin polarized cells per ×400 field in control and MYO9B knockdown Jurkat T cells seeded onto denatured collagen-IV. Data represent percentage of F-actin polarized T cells from two independent experiments calculated from 10 ×400 microscopic fields per condition. Data are given as means ± SEM ( C , D , H – J , and L ). ∗ P < 0.05, ∗∗ P < 0.01. Scale bars = 20 μm ( K ).
    Active Rho Detection Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a+rho+activation+assay+kit/Active+Rho+Detection+Kit/pmc12881303-47-6-10
    Average 93 stars, based on 1 article reviews
    active rho detection kit - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    active rho assay kits  (Cell Signaling Technology Inc)
    93
    Cell Signaling Technology Inc active rho assay kits
    <t>RHOA</t> and MYO9B play roles in the ability of the RGDKGE collagen peptide (P2) to modulate CD8 + T-cell migration on denatured collagen-IV (Den-Coll-IV). A and B: Whole cell lysates were prepared from Jurkat T cells treated with the P2 or control peptide (CP; A ) or dimethyl sulfoxide (DMSO) buffer control or RHOA inhibitor rhosin ( B ) and analyzed by Western blot analysis for total and activated RHOA using an active <t>RHO</t> detection kit. C and D: Quantification of Jurkat T-cell migration on denatured collagen-IV ( C ) or native collagen-IV (Nat-Coll-IV; D ) in the presence of DMSO or RHOA inhibitor rhosin. C: Data represent change in cell migration from four independent experiments with control DMSO treatment set to 100% for comparison. D: Data represent change in cell migration from three independent experiments with control DMSO treatment set to 100% for comparison. E and F: Cell lysates were prepared from Jurkat T cells treated with the P2 or CP ( E ) or DMSO or SRC non-receptor tyrosine kinase (SRC) inhibitor ( F ), and analyzed by Western blot analysis for MYO9B. G: Western blot analysis for MYO9B levels in control or MYO9B-specific siRNA-transfected Jurkat T cells. H and I: Quantification of control and MYO9B-specific knockdown Jurkat T-cell migration on denatured collagen-IV ( H ) or native collagen-IV ( I ). H: Data represent change in cell migration from four independent experiments with control siRNA treatment set to 100% for comparison. I: Data represent change in cell migration from two independent experiments with control siRNA treatment set to 100% for comparison. J: Quantification of MYO9B knockdown Jurkat T-cell migration on denatured collagen-IV in the presence of CP or P2. Data represent change in cell migration from three independent experiments with control CP treatment set to 100% for comparison. K: Example of F-actin polarization ( arrows ) in control or MYO9B-specific siRNA-transfected Jurkat T cells seeded onto denatured collagen-IV. L: Quantification of the mean percentage of F-actin polarized cells per ×400 field in control and MYO9B knockdown Jurkat T cells seeded onto denatured collagen-IV. Data represent percentage of F-actin polarized T cells from two independent experiments calculated from 10 ×400 microscopic fields per condition. Data are given as means ± SEM ( C , D , H – J , and L ). ∗ P < 0.05, ∗∗ P < 0.01. Scale bars = 20 μm ( K ).
    Active Rho Assay Kits, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a+rho+activation+assay+kit/Active+Rho+Detection+Kit/pm41571340-72-10-18
    Average 93 stars, based on 1 article reviews
    active rho assay kits - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    RHOA and MYO9B play roles in the ability of the RGDKGE collagen peptide (P2) to modulate CD8 + T-cell migration on denatured collagen-IV (Den-Coll-IV). A and B: Whole cell lysates were prepared from Jurkat T cells treated with the P2 or control peptide (CP; A ) or dimethyl sulfoxide (DMSO) buffer control or RHOA inhibitor rhosin ( B ) and analyzed by Western blot analysis for total and activated RHOA using an active RHO detection kit. C and D: Quantification of Jurkat T-cell migration on denatured collagen-IV ( C ) or native collagen-IV (Nat-Coll-IV; D ) in the presence of DMSO or RHOA inhibitor rhosin. C: Data represent change in cell migration from four independent experiments with control DMSO treatment set to 100% for comparison. D: Data represent change in cell migration from three independent experiments with control DMSO treatment set to 100% for comparison. E and F: Cell lysates were prepared from Jurkat T cells treated with the P2 or CP ( E ) or DMSO or SRC non-receptor tyrosine kinase (SRC) inhibitor ( F ), and analyzed by Western blot analysis for MYO9B. G: Western blot analysis for MYO9B levels in control or MYO9B-specific siRNA-transfected Jurkat T cells. H and I: Quantification of control and MYO9B-specific knockdown Jurkat T-cell migration on denatured collagen-IV ( H ) or native collagen-IV ( I ). H: Data represent change in cell migration from four independent experiments with control siRNA treatment set to 100% for comparison. I: Data represent change in cell migration from two independent experiments with control siRNA treatment set to 100% for comparison. J: Quantification of MYO9B knockdown Jurkat T-cell migration on denatured collagen-IV in the presence of CP or P2. Data represent change in cell migration from three independent experiments with control CP treatment set to 100% for comparison. K: Example of F-actin polarization ( arrows ) in control or MYO9B-specific siRNA-transfected Jurkat T cells seeded onto denatured collagen-IV. L: Quantification of the mean percentage of F-actin polarized cells per ×400 field in control and MYO9B knockdown Jurkat T cells seeded onto denatured collagen-IV. Data represent percentage of F-actin polarized T cells from two independent experiments calculated from 10 ×400 microscopic fields per condition. Data are given as means ± SEM ( C , D , H – J , and L ). ∗ P < 0.05, ∗∗ P < 0.01. Scale bars = 20 μm ( K ).

    Journal: The American Journal of Pathology

    Article Title: Inhibiting the Secreted RGDKGE Collagen Peptide Selectively Controls CD8 + T-Cell Migration on Denatured Collagen-IV and Enhances Their Accumulation in Tumors

    doi: 10.1016/j.ajpath.2025.09.008

    Figure Lengend Snippet: RHOA and MYO9B play roles in the ability of the RGDKGE collagen peptide (P2) to modulate CD8 + T-cell migration on denatured collagen-IV (Den-Coll-IV). A and B: Whole cell lysates were prepared from Jurkat T cells treated with the P2 or control peptide (CP; A ) or dimethyl sulfoxide (DMSO) buffer control or RHOA inhibitor rhosin ( B ) and analyzed by Western blot analysis for total and activated RHOA using an active RHO detection kit. C and D: Quantification of Jurkat T-cell migration on denatured collagen-IV ( C ) or native collagen-IV (Nat-Coll-IV; D ) in the presence of DMSO or RHOA inhibitor rhosin. C: Data represent change in cell migration from four independent experiments with control DMSO treatment set to 100% for comparison. D: Data represent change in cell migration from three independent experiments with control DMSO treatment set to 100% for comparison. E and F: Cell lysates were prepared from Jurkat T cells treated with the P2 or CP ( E ) or DMSO or SRC non-receptor tyrosine kinase (SRC) inhibitor ( F ), and analyzed by Western blot analysis for MYO9B. G: Western blot analysis for MYO9B levels in control or MYO9B-specific siRNA-transfected Jurkat T cells. H and I: Quantification of control and MYO9B-specific knockdown Jurkat T-cell migration on denatured collagen-IV ( H ) or native collagen-IV ( I ). H: Data represent change in cell migration from four independent experiments with control siRNA treatment set to 100% for comparison. I: Data represent change in cell migration from two independent experiments with control siRNA treatment set to 100% for comparison. J: Quantification of MYO9B knockdown Jurkat T-cell migration on denatured collagen-IV in the presence of CP or P2. Data represent change in cell migration from three independent experiments with control CP treatment set to 100% for comparison. K: Example of F-actin polarization ( arrows ) in control or MYO9B-specific siRNA-transfected Jurkat T cells seeded onto denatured collagen-IV. L: Quantification of the mean percentage of F-actin polarized cells per ×400 field in control and MYO9B knockdown Jurkat T cells seeded onto denatured collagen-IV. Data represent percentage of F-actin polarized T cells from two independent experiments calculated from 10 ×400 microscopic fields per condition. Data are given as means ± SEM ( C , D , H – J , and L ). ∗ P < 0.05, ∗∗ P < 0.01. Scale bars = 20 μm ( K ).

    Article Snippet: To detect active RHOA, the (Rhotekin-RBD) active RHO detection kit (Cell Signaling) was used.

    Techniques: Migration, Control, Western Blot, Comparison, Transfection, Knockdown